GB0903848D0 - Methods and compositions for highly sensitive detection of molecules - Google Patents

Methods and compositions for highly sensitive detection of molecules

Info

Publication number
GB0903848D0
GB0903848D0 GBGB0903848.0A GB0903848A GB0903848D0 GB 0903848 D0 GB0903848 D0 GB 0903848D0 GB 0903848 A GB0903848 A GB 0903848A GB 0903848 D0 GB0903848 D0 GB 0903848D0
Authority
GB
United Kingdom
Prior art keywords
molecules
compositions
methods
highly sensitive
sensitive detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0903848.0A
Other versions
GB2458025A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Singulex Inc
Original Assignee
Singulex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/036086 external-priority patent/WO2009126380A2/en
Application filed by Singulex Inc filed Critical Singulex Inc
Publication of GB0903848D0 publication Critical patent/GB0903848D0/en
Publication of GB2458025A publication Critical patent/GB2458025A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/412—Detecting or monitoring sepsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/515—Angiogenesic factors; Angiogenin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB0903848A 2008-03-05 2009-03-05 Methods of detecting cardiac troponin using a single molecule detector Withdrawn GB2458025A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3389708P 2008-03-05 2008-03-05
US3871408P 2008-03-21 2008-03-21
PCT/US2009/036086 WO2009126380A2 (en) 2008-03-05 2009-03-04 Methods and compositions for highly sensitive detection of molecules
US12/398,175 US20090234202A1 (en) 2008-03-05 2009-03-04 Method and compositions for highly sensitive detection of molecules

Publications (2)

Publication Number Publication Date
GB0903848D0 true GB0903848D0 (en) 2009-04-22
GB2458025A GB2458025A (en) 2009-09-09

Family

ID=40600588

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0903848A Withdrawn GB2458025A (en) 2008-03-05 2009-03-05 Methods of detecting cardiac troponin using a single molecule detector

Country Status (1)

Country Link
GB (1) GB2458025A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109328303A (en) * 2016-06-17 2019-02-12 豪夫迈·罗氏有限公司 For predicting that the systemic vascular of the recurrence of atrial fibrillation generates -2 (Ang-2) of element

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2464183A (en) * 2008-09-19 2010-04-14 Singulex Inc Sandwich assay
EP3225994A1 (en) 2010-08-26 2017-10-04 Roche Diagnostics GmbH Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
CN114836542A (en) * 2022-05-30 2022-08-02 南方科技大学 Application of neuroendocrine tumor biomarker in preparation of neuroendocrine tumor diagnostic reagent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9040305B2 (en) * 2004-09-28 2015-05-26 Singulex, Inc. Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry
AU2005290314A1 (en) * 2004-09-28 2006-04-06 Singulex, Inc. System and method for spectroscopic analysis of single particles
EP3495822B1 (en) * 2006-04-04 2023-12-20 Novilux, LLC Method for assessing acute myocardial infarction based on highly sensitive analysis of cardiac troponin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109328303A (en) * 2016-06-17 2019-02-12 豪夫迈·罗氏有限公司 For predicting that the systemic vascular of the recurrence of atrial fibrillation generates -2 (Ang-2) of element

Also Published As

Publication number Publication date
GB2458025A (en) 2009-09-09

Similar Documents

Publication Publication Date Title
EP2263085A4 (en) Methods and compositions for highly sensitive detection of molecules
HUS1900004I1 (en) Compositions and methods for inhibiting expression of transthyretin
EP2353005A4 (en) Methods and compositions for detection of complement fixing antibodies
EP2016394A4 (en) Methods and compositions for highly sensitive analysis of markers and detection of molecules
HK1144319A1 (en) Compositions and methods of detecting tiabs
IL217769A (en) Device for detection of target molecules and uses thereof
EP2419537A4 (en) Methods and compositions for detection of small rnas
EP2430446A4 (en) Methods and compositions for analyte detection
EP2299903A4 (en) Detection meter and mode of operation
GB201104774D0 (en) Device for measuring physical property of particle
ZA201101745B (en) System and method for detection of malware
EP2344962A4 (en) Detection of confidential information
GB201012802D0 (en) Methodology for interpretation and analysis of distributions
EP2346905A4 (en) Methods and compositions for treatment of myotonic dystrophy
ZA201001878B (en) Improved detection of mage-a-expression
EP2321426A4 (en) Compositions for detecting cell death and methods of use thereof
EP2408465A4 (en) Methods and compositions for the detection of cancer
HK1140019A1 (en) Compositions and methods of detection
EP2334814A4 (en) Methods and compositions for direct detection of dna damage
EP2376923A4 (en) Methods for detection of sepsis
IL213267A0 (en) Method and system for detecting small amounts of substances
EP2473621A4 (en) Methods and compositions for detection of lethal cell and uses thereof
EP2309397A4 (en) Device and method for supporting detection of mistranslation
EP2333109A4 (en) Composition for detection of rna
EP2288725A4 (en) Methods of determining properties of molecules

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)